Read More Pharma Industry News Appili Therapeutics faces funding reset after NIAID terminates VXV-01 contract Appili Therapeutics faces a funding reset after NIAID ended its VXV-01 contract. Discover what the termination means for APLI investors. bySrinathJuly 5, 2026